Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-05-006491
Filing Date
2005-11-14
Accepted
2005-11-14 16:54:58
Documents
10
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 VIACELL, INC. b57619vce10vq.htm 10-Q 419677
2 EX-10.1 AMENDMENT NO. 1 TO COLLABORATION AGREEMENT, DATED AUGUST 29, 2005 b57619vcexv10w1.txt EX-10.1 16672
3 EX-10.2 WARRANT PURCHASE AGREEMENT, DATED AUGUST 29, 2005 b57619vcexv10w2.txt EX-10.2 100337
4 EX-10.3 PURCHASE WARRANT, DATED AUGUST 29, 2005 b57619vcexv10w3.txt EX-10.3 26991
5 EX-10.4 EXCLUSIVE LICENSE AGREEMENT, DATED AUGUST 29, 2005 b57619vcexv10w4.txt EX-10.4 63549
6 EX-10.5 LETTER AGREEMENT DATED AUGUST 1, 2005 b57619vcexv10w5.txt EX-10.5 10771
7 EX-31.1 SECTION 302 CERTIFICATION OF CEO b57619vcexv31w1.htm EX-31.1 5295
8 EX-31.2 SECTION 302 CERTIFICATION OF CFO b57619vcexv31w2.htm EX-31.2 5259
9 EX-32.1 SECTION 906 CERTIFICATION OF CEO b57619vcexv32w1.htm EX-32.1 2498
10 EX-32.2 SECTION 906 CERTIFICATION OF CFO b57619vcexv32w2.htm EX-32.2 2465
  Complete submission text file 0000950135-05-006491.txt   654763
Mailing Address
Business Address 131 CLARENDON ST BOSTON MA 02116 6172664373
VIACELL INC (Filer) CIK: 0001114529 (see all company filings)

EIN.: 043244816
Type: 10-Q | Act: 34 | File No.: 000-51110 | Film No.: 051202486
SIC: 8731 Services-Commercial Physical & Biological Research